Modeling the effects of prior infection on vaccine efficacy
Conference
·
OSTI ID:542068
- Univ. of New Mexico, Albuquerque, NM (United States). Dept. of Computer Science
- Los Alamos National Lab., NM (United States)
We performed computer simulations to study the effects of prior infection on vaccine efficacy. We injected three antigens sequentially. The first antigen, designated the prior, represented a prior infection or vaccination. The second antigen, the vaccine, represented a single component of the trivalent influenza vaccine. The third antigen, the epidemic, represented challenge by an epidemic strain. For a fixed vaccine to epidemic strain cross-reactivities to the vaccine and to the epidemic strains. We found that, for many cross-reactivities, vaccination, when it had been preceded by a prior infection, provided more protection than vaccination alone. However, at some cross-reactivities, the prior infection reduced protection by clearing the vaccine before it had the chance to produce protective memory. The cross-reactivities between the prior, vaccine and epidemic strains played a major role in determining vaccine efficacy. This work has applications to understanding vaccination against viruses such as influenza that are continually mutating.
- Research Organization:
- Los Alamos National Lab., NM (United States)
- Sponsoring Organization:
- USDOE Assistant Secretary for Human Resources and Administration, Washington, DC (United States); Office of Naval Research, Washington, DC (United States); National Science Foundation, Washington, DC (United States)
- DOE Contract Number:
- W-7405-ENG-36
- OSTI ID:
- 542068
- Report Number(s):
- LA-UR--97-2618; CONF-971068--; ON: DE98000833; CNN: Contract N00014-95-1-0364; Grant IRI-9157644
- Country of Publication:
- United States
- Language:
- English
Similar Records
Modeling the effects of annual influenza vaccination
Vaccine-Associated Enhanced Respiratory Disease following Influenza Virus Infection in Ferrets Recapitulates the Model in Pigs
The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain
Technical Report
·
Wed Dec 30 23:00:00 EST 1998
·
OSTI ID:314169
Vaccine-Associated Enhanced Respiratory Disease following Influenza Virus Infection in Ferrets Recapitulates the Model in Pigs
Journal Article
·
Tue Mar 08 19:00:00 EST 2022
· Journal of Virology
·
OSTI ID:1982977
The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain
Journal Article
·
Sun Aug 11 20:00:00 EDT 2019
· Nature Microbiology
·
OSTI ID:1599430